These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26629)

  • 41. High prekallikrein levels during pregnancy.
    Marcel GA; Caspar C; Sabatier C; Gautray J; Schirar A
    Pathol Biol (Paris); 1975 Dec; 23 suppl():66-8. PubMed ID: 772561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kallikrein and prekallikrein determination in a number of pathological conditions using the Centrifichem analyzer.
    Creter D; Allalouf D
    Ann Allergy; 1982 Jun; 48(6):349-50. PubMed ID: 6920247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs.
    Aasen AO; Frolich W; Saugstad OD; Amundsen E
    Eur Surg Res; 1978; 10(1):50-62. PubMed ID: 344043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
    Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L
    Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chromogenic substrate assays for studying components of the plasma kallikrein system in health and disease.
    Gallimore MJ
    Adv Exp Med Biol; 1983; 156():225-31. PubMed ID: 6552839
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of a chromatographic method for determining kallikrein and prekallikrein in dog blood serum].
    Dotsenko VL; Saiapin VN; Neshkova EA; Iarovaia GA
    Biull Eksp Biol Med; 1982 Aug; 94(8):117-20. PubMed ID: 6922725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new automated method for kallikrein-prekallikrein determination.
    Creter D
    Haematologica; 1987; 72(3):281. PubMed ID: 3114100
    [No Abstract]   [Full Text] [Related]  

  • 49. Electrochemical activity determination of trypsin-like enzymes. VIII. Kallikrein and prekallikrein in plasma and whole blood.
    Corretge E; Nigretto JM
    Thromb Res; 1984 Dec; 36(6):563-70. PubMed ID: 6570370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [On the determination of plasma prekallikrein with chromogenic peptide substrate (author's transl)].
    Nakamura S; Takizawa N; Nakanishi K; Igarashi M
    Rinsho Byori; 1980 Jul; 28(7):670-4. PubMed ID: 6906394
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Determination of plasma kallikrein and prekallikrein in patients with epidemic hemorrhagic fever and its clinical significance].
    Tong MQ
    Zhonghua Yi Xue Za Zhi; 1987 May; 67(5):256-7. PubMed ID: 2888524
    [No Abstract]   [Full Text] [Related]  

  • 54. [Determination of plasma prekallikrein using beta-XIIa (Hageman factor fragment)].
    Komiyama Y; Egawa H; Murata K
    Rinsho Byori; 1984 May; 32(5):558-62. PubMed ID: 6332927
    [No Abstract]   [Full Text] [Related]  

  • 55. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J; Huyke R; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):492-6. PubMed ID: 6083916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity and specificity of plasma serine protease chromogenic substrates.
    Bang NU; Mattler LE
    Haemostasis; 1978; 7(2-3):98-104. PubMed ID: 149051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma total prekallikrein/kallikrein activity in rheumatoid arthritis with and without amyloidosis. Increased kaolin-stimulated activity in patients with amyloidosis.
    Teppo AM; Pakkanen R; Maury CP
    Acta Med Scand; 1985; 217(4):397-402. PubMed ID: 2409750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.